FARS2 dificiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance
Mol Genet Metab 125:281-291, Almannai, M.,et al, 2018
Cerebral Palsy
Lancet 383:1240-1248, Colver, A.,et al, 2014
Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010
Cerebral Palsy
Lancet 363:1619-1631, Koman,L.A.,et al, 2004
Botulinum Toxin in the Cerebral Palsies
BMJ 309:1526-1527, Neville,B., 1994
Magnetic Resonance Imaging of Brain and the Neuromotor Disorder in Endemic Cretinism
Ann Neurol 34:91-94, Ma,T.,et al, 1993
Arginase Deficiency Presenting as Cerebral Palsy
Pediatrics 91:995-996, Scheuerle,A.E.,et al, 1993
Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin
JAMA 270:2475-2477, Albright,A.L.,et al, 1993
Intrathecal Baclofen for Spasticity in Cerebral Palsy
JAMA 265:1418-1422, Albright,A.L.,et al, 1991
New Muscle Power Test in Neuromuscular Disease
Am J Dis Child 144:1083-1087, Tirosh,E.,et al, 1990
Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989
The Causes of Cerebral Palsy
JAMA 247:1473-1477, Holm,V.A., 1982